Wedbush Securities Inc Danaher Corp Transaction History

Wedbush Securities Inc

$2.81 Billion
Q4 2024

A detailed history of Wedbush Securities Inc transactions in Danaher Corp stock. As of the latest transaction made, Wedbush Securities Inc holds 4,358 shares of DHR stock, worth $887,245. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,358

Previous 4,695 7.18%

Holding current value

$887,245

Previous $1.31 Million 23.37%

% of portfolio

0.04%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$226.16 - $274.52 $76,215 - $92,513	-337 Reduced 7.18%	4,358 $1 Million
Q3 2024 Nov 08, 2024	SELL	$239.25 - $280.76 $456,010 - $535,128	-1,906 Reduced 28.87%	4,695 $1.31 Million
Q2 2024 Aug 06, 2024	SELL	$235.51 - $267.98 $345,728 - $393,394	-1,468 Reduced 18.19%	6,601 $1.65 Million
Q1 2024 May 14, 2024	BUY	$224.58 - $256.19 $393,688 - $449,101	1,753 Added 27.75%	8,069 $2.02 Million
Q4 2023 Feb 12, 2024	SELL	$185.1 - $233.13 $37,020 - $46,626	-200 Reduced 3.07%	6,316 $1.46 Million
Q3 2023 Nov 14, 2023	SELL	$233.08 - $265.59 $19,578 - $22,309	-84 Reduced 1.27%	6,516 $1.62 Million
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $327,810 - $373,195	1,457 Added 28.33%	6,600 $1.58 Million
Q1 2023 May 09, 2023	SELL	$239.75 - $277.0 $80,076 - $92,518	-334 Reduced 6.1%	5,143 $1.3 Million
Q4 2022 Jan 31, 2023	SELL	$241.42 - $282.29 $29,453 - $34,439	-122 Reduced 2.18%	5,477 $1.45 Million
Q3 2022 Oct 18, 2022	BUY	$247.06 - $1507.4 $177,389 - $1.08 Million	718 Added 14.71%	5,599 $1.45 Million
Q2 2022 Jul 21, 2022	SELL	$237.11 - $299.66 $101,720 - $128,554	-429 Reduced 8.08%	4,881 $1.24 Million
Q1 2022 Apr 19, 2022	SELL	$257.27 - $315.76 $33,959 - $41,680	-132 Reduced 2.43%	5,310 $1.56 Million
Q4 2021 Jan 13, 2022	BUY	$292.08 - $329.01 $15,480 - $17,437	53 Added 0.98%	5,442 $1.79 Million
Q3 2021 Oct 08, 2021	SELL	$272.21 - $332.43 $157,609 - $192,476	-579 Reduced 9.7%	5,389 $1.64 Million
Q2 2021 Jul 27, 2021	SELL	$225.08 - $271.69 $20,707 - $24,995	-92 Reduced 1.52%	5,968 $1.6 Million
Q1 2021 Apr 26, 2021	BUY	$212.38 - $245.9 $70,934 - $82,130	334 Added 5.83%	6,060 $1.36 Million
Q4 2020 Feb 16, 2021	SELL	$212.5 - $245.46 $1.42 Million - $1.64 Million	-6,675 Reduced 53.83%	5,726 $1.27 Million
Q3 2020 Oct 20, 2020	SELL	$177.16 - $215.33 $312,333 - $379,626	-1,763 Reduced 12.45%	12,401 $2.67 Million
Q2 2020 Jul 16, 2020	SELL	$128.7 - $176.83 $3,217 - $4,420	-25 Reduced 0.18%	14,164 $2.51 Million
Q1 2020 Apr 17, 2020	SELL	$121.39 - $169.05 $22,335 - $31,105	-184 Reduced 1.28%	14,189 $1.96 Million
Q4 2019 Jan 16, 2020	SELL	$133.47 - $153.48 $140,944 - $162,074	-1,056 Reduced 6.84%	14,373 $2.21 Million
Q3 2019 Oct 17, 2019	BUY	$135.4 - $146.47 $13,540 - $14,647	100 Added 0.65%	15,429 $2.23 Million
Q2 2019 Aug 01, 2019	SELL	$124.88 - $143.73 $90,288 - $103,916	-723 Reduced 4.5%	15,329 $2.19 Million
Q1 2019 Apr 17, 2019	SELL	$97.62 - $132.29 $29,383 - $39,819	-301 Reduced 1.84%	16,052 $2.12 Million
Q4 2018 Jan 31, 2019	BUY	$94.85 - $109.54 $17,357 - $20,045	183 Added 1.13%	16,353 $1.69 Million
Q3 2018 Nov 13, 2018	BUY	$98.13 - $108.9 $9,322 - $10,345	95 Added 0.59%	16,170 $1.76 Million
Q2 2018 Aug 03, 2018	BUY	$96.1 - $103.24 $123,104 - $132,250	1,281 Added 8.66%	16,075 $1.59 Million
Q1 2018 May 01, 2018	SELL	$92.16 - $103.8 $476,743 - $536,957	-5,173 Reduced 25.91%	14,794 $1.45 Million
Q4 2017 Feb 09, 2018	SELL	$85.26 - $94.62 $119,790 - $132,941	-1,405 Reduced 6.57%	19,967 $1.85 Million
Q3 2017 Oct 31, 2017	BUY	$79.29 - $88.45 $1.69 Million - $1.89 Million	21,372	21,372 $1.83 Million

Others Institutions Holding DHR

# of Institutions

2,505

Shares Held

549M

Call Options Held

7.03M

Put Options Held

4.69M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $148B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Account

Wedbush Securities Inc Danaher Corp Transaction History